Single-base LOH Can Be Used As Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Wang G, Zhang D, Zhuang H, Yin C, Liu J, Wang Z Chin Med J (Engl). 2017; 130(18):2176-2182.
PMID: 28875953 PMC: 5598329. DOI: 10.4103/0366-6999.213962.
References
1.
Fernandez-Ramires R, Gomez G, Munoz-Repeto I, De Cecco L, Llort G, Cazorla A
. Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors. Int J Cancer. 2010; 128(11):2635-44.
DOI: 10.1002/ijc.25603.
View
2.
Melchor L, Honrado E, Garcia M, Alvarez S, Palacios J, Osorio A
. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Oncogene. 2007; 27(22):3165-75.
DOI: 10.1038/sj.onc.1210975.
View
3.
Osorio A, de la Hoya M, Rodriguez-Lopez R, Martinez-Ramirez A, Cazorla A, Granizo J
. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer. 2002; 99(2):305-9.
DOI: 10.1002/ijc.10337.
View
4.
Da Silva L, Lakhani S
. Pathology of hereditary breast cancer. Mod Pathol. 2010; 23 Suppl 2:S46-51.
DOI: 10.1038/modpathol.2010.37.
View
5.
Honrado E, Osorio A, Milne R, Paz M, Melchor L, Cascon A
. Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pathol. 2007; 20(12):1298-306.
DOI: 10.1038/modpathol.3800969.
View